Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: A multicentre retrospective study

Clinical Endocrinology

Volumn 63, Issue 1, 2005, Pages 19-25

  Melis, Daniela ^a   Parenti, G ^a   Gatti, R ^b   Della Casa, R ^a   Parini, R ^c   Riva, E ^d   Burlina, A B ^e   Vici, C Dionisi ^f   Di Rocco, M ^b   Furlan, F ^c   Torcoletti, M ^d   Papadia, F ^g   Donati, A ^h   Benigno, V ⁱ   Andria, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d SAN PAOLO HOSPITAL   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ Ospedale S Giovanni di Dio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; RAMIPRIL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; INFANT; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; INFANT; KIDNEY DISEASES; PROTEINURIA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 22044453413     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02292.x     Document Type: Article

References (25)

1. Chen, Y.T. (2001) Glycogen storage disease. In: C.R. Scriver, A.L. Beaudet, D. Valle, W.S. Sly, V. Kinder eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, 1521-1551.
2. Lei, K.J., Shelly, L.L., Lin, B., Sidbury, J.B., Chen, Y.T., Nordlie, R.C. & Chou, J.Y. (1995) Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. Journal of Clinical Investigation, 95, 234-240.
3. Marcolongo, P., Barone, V., Priori, G., Pirola, B., Giglio, S., Biasucci, G., Zammarchi, E., Parenti, G., Burchell, A., Benedetti, A. & Sorrentino, V. (1998) Structure and mutation analysis of the glycogen storage disease type 1b gene. FEBS Letter, 436, 247-250.
4. Galli, L., Orrico, A., Marcolongo, P., Fulceri, R., Burchell, A., Melis, D., Parini, R., Gatti, R., Lam, C., Benedetti, A. & Sorrentino, V. (1999) Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c. FEBS Letters, 459, 255-258.
5. Fernandes, J., Jansen, H. & Jansen, T.C. (1984) Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children. Pediatric Research, 18, 879-881.
6. Smit, G.P., Berger, R., Potasnick, R., Moses, S.W. & Fernandes, J. (1979) The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatric Research, 13, 225-229.
7. Rake, J.P., Visser, G., Labrune, P., Leonard, J.V., Ullrich, K. & Smit, G.P.A. (2002) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease type I (ESGSDI). European Journal of Pediatrics, 161, S20-S34.
8. Chen, Y.-T., Coleman, R.A, Scheiman, J.I., Kolbeck, P.C. & Sidbury, J.B. (1988) Renal disease in type I glycogen storage disease. New England Journal of Medicine, 318, 7-11.
9. Baker, L., Dahlem, S., Goldfarb, S., Kern, E.F., Stanley, C.A., Egler, J., Olshan, J.S. & Heyman, S. (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney International, 35, 1345-1350.
10. Chen, Y.T. (1991) Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatric Nephrology, 5, 71-76.
11. Wolfsdorf, J.I., Laffel, L.M. & Crigler, J.F. Jr (1997) Metabolic control and renal dysfunction in type I glycogen storage disease. Journal of Inherited Metabolic Disease, 20, 559-568.
12. Lee, P.J., Neil Dalton, R., Shah, V., Hinmarsh, P.C. & Leonard, J.V. (1995) Glomerular and tubular function in glycogen storage disease. Pediatric Nephrology, 9, 705-710.
13. Obara, K., Saito, T., Sato, H., Ogawa, M., Igarashi, Y. & Yoshinaga, K. (1993) Renal histology in two adult patients with type glycogen storage disease. Clinical Nephrology, 39, 59-64.
14. Mundy, H.R. & Lee, P.J. (2002) Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction? Medical Hypotheses, 59, 110-114.
15. Mathiesen, E.R., Hommel, E., Hansen, H.P., Smidt, U.M. & Parving, H.H. (1999) Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. British Medical Journal, 319, 24-25.
16. Perkins, B.A., Ficociello, L.H., Silva, K.H., Finkelstein, D.M., Warram, J.H. & Krolewski, A.S. (2003) Regression of microalbuminuria in type1 diabetes. New England Journal of Medicine, 348, 2285-2293.
17. Baker, L., Kern, E.F.O., Olshan, J., Goldfarb, S. & Dahlem, S.T. (1988) Pilot study of captopril in patients with renal disease associated with glycogen storage disease, type I (GSDI). Pediatric Research, 23, 388A.
18. Ozen, H., Ciliv, G., Kocak, N., Saltik, I.N., Yuce, A. & Gurakan, F. (2000) Short-term effect of captopril on microalbuminuria in children with glycogen storage disease type Ia. Journal of Inherited Metabolic Disease, 23, 459-463.
19. Pela, I., Donati, M.A. & Zammarchi, E. (2001) Effect of Ramipril in a patient with glycogen storage disease type I and nephritic-range proteinuria. Journal of Inherited Metabolic Disease, 24, 681-682.
20. Giannì, M.L., Bonvissuto, M., Gallieni, M., Testolin, C., Racchi, E. & Riva, E. (2002) Ramipril treatment in a patient with glycogen storage disease I non-a. Journal of Inherited Metabolic Disease, 25, 515-516.
21. McCrory, W.W. (1972) Developmental Nephrology. Harvard University Press, Cambridge.
22. Ruggenenti, P., Perna, A., Mosocni, L., Pisoni, R. & Remuzzi, G. (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney International, 53, 1209-1216.
23. Matsuda, H., Hayashi, K., Wakino, S., Kubota, E., Honda, M., Tokuyama, H., Takamatsu, I., Tatematsu, S. & Saruta, T. (2004) Role of endothelium-derived hyperpolarizing factor in A.C.E. inhibitor-induced renal vasodilation in vivo. Hypertension, 43, 603-609.
24. Ichikawa, I. & Fogo, A. (1996) Focal segmental glomerulosclerosis. Pediatric Nephrology, 10, 374-391.
25. Henriksen, E.J. & Jacob, S. (2003) Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. Journal of Cell Physiology, 196, 171-179.